Logo image of VLN

VALENS SEMICONDUCTOR LTD (VLN) Stock Fundamental Analysis

USA - NYSE:VLN - IL0011796880 - Common Stock

1.9 USD
+0.04 (+2.15%)
Last: 10/3/2025, 8:10:48 PM
1.98 USD
+0.08 (+4.21%)
After Hours: 10/3/2025, 8:10:48 PM
Fundamental Rating

3

Overall VLN gets a fundamental rating of 3 out of 10. We evaluated VLN against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for VLN as it has an excellent financial health rating, but there are worries on the profitability. VLN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year VLN has reported negative net income.
VLN had a negative operating cash flow in the past year.
VLN had negative earnings in each of the past 5 years.
In the past 5 years VLN reported 4 times negative operating cash flow.
VLN Yearly Net Income VS EBIT VS OCF VS FCFVLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M

1.2 Ratios

VLN has a worse Return On Assets (-23.67%) than 81.25% of its industry peers.
VLN's Return On Equity of -28.45% is on the low side compared to the rest of the industry. VLN is outperformed by 76.79% of its industry peers.
Industry RankSector Rank
ROA -23.67%
ROE -28.45%
ROIC N/A
ROA(3y)-15.43%
ROA(5y)-16.83%
ROE(3y)-18.04%
ROE(5y)-19.57%
ROIC(3y)N/A
ROIC(5y)N/A
VLN Yearly ROA, ROE, ROICVLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

VLN has a better Gross Margin (59.24%) than 84.82% of its industry peers.
VLN's Gross Margin has declined in the last couple of years.
VLN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.1%
GM growth 5Y-5.61%
VLN Yearly Profit, Operating, Gross MarginsVLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

7

2. Health

2.1 Basic Checks

VLN does not have a ROIC to compare to the WACC, probably because it is not profitable.
VLN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, VLN has less shares outstanding
There is no outstanding debt for VLN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VLN Yearly Shares OutstandingVLN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
VLN Yearly Total Debt VS Total AssetsVLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

VLN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC10.99%
VLN Yearly LT Debt VS Equity VS FCFVLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

VLN has a Current Ratio of 8.10. This indicates that VLN is financially healthy and has no problem in meeting its short term obligations.
VLN has a better Current ratio (8.10) than 89.29% of its industry peers.
VLN has a Quick Ratio of 7.46. This indicates that VLN is financially healthy and has no problem in meeting its short term obligations.
VLN's Quick ratio of 7.46 is amongst the best of the industry. VLN outperforms 89.29% of its industry peers.
Industry RankSector Rank
Current Ratio 8.1
Quick Ratio 7.46
VLN Yearly Current Assets VS Current LiabilitesVLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

4

3. Growth

3.1 Past

The earnings per share for VLN have decreased by 0.00% in the last year.
The Revenue for VLN has decreased by -31.25% in the past year. This is quite bad
VLN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.74% yearly.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-31.25%
Revenue growth 3Y-6.45%
Revenue growth 5Y-0.74%
Sales Q2Q%25.46%

3.2 Future

The Earnings Per Share is expected to grow by 31.19% on average over the next years. This is a very strong growth
Based on estimates for the next years, VLN will show a very strong growth in Revenue. The Revenue will grow by 28.25% on average per year.
EPS Next Y-16.99%
EPS Next 2Y1.34%
EPS Next 3Y5.22%
EPS Next 5Y31.19%
Revenue Next Year18.09%
Revenue Next 2Y18.02%
Revenue Next 3Y20.36%
Revenue Next 5Y28.25%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
VLN Yearly Revenue VS EstimatesVLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
VLN Yearly EPS VS EstimatesVLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 -0.4

0

4. Valuation

4.1 Price/Earnings Ratio

VLN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year VLN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VLN Price Earnings VS Forward Price EarningsVLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VLN Per share dataVLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.34%
EPS Next 3Y5.22%

0

5. Dividend

5.1 Amount

VLN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VALENS SEMICONDUCTOR LTD

NYSE:VLN (10/3/2025, 8:10:48 PM)

After market: 1.98 +0.08 (+4.21%)

1.9

+0.04 (+2.15%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners34.11%
Inst Owner Change0%
Ins Owners7.78%
Ins Owner ChangeN/A
Market Cap199.29M
Analysts82.5
Price Target4.08 (114.74%)
Short Float %0.42%
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.49%
Min EPS beat(2)0.99%
Max EPS beat(2)33.99%
EPS beat(4)4
Avg EPS beat(4)31.14%
Min EPS beat(4)0.99%
Max EPS beat(4)50.5%
EPS beat(8)7
Avg EPS beat(8)99.12%
EPS beat(12)11
Avg EPS beat(12)87.92%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.49%
Min Revenue beat(2)1.13%
Max Revenue beat(2)1.85%
Revenue beat(4)4
Avg Revenue beat(4)3.51%
Min Revenue beat(4)1.13%
Max Revenue beat(4)5.9%
Revenue beat(8)5
Avg Revenue beat(8)2.07%
Revenue beat(12)8
Avg Revenue beat(12)1.7%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-63.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.44
P/FCF N/A
P/OCF N/A
P/B 1.55
P/tB 1.63
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.55
BVpS1.23
TBVpS1.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.67%
ROE -28.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.24%
FCFM N/A
ROA(3y)-15.43%
ROA(5y)-16.83%
ROE(3y)-18.04%
ROE(5y)-19.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.1%
GM growth 5Y-5.61%
F-Score3
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 76.71%
Cap/Sales 3.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.1
Quick Ratio 7.46
Altman-Z N/A
F-Score3
WACC10.99%
ROIC/WACCN/A
Cap/Depr(3y)75.46%
Cap/Depr(5y)87.24%
Cap/Sales(3y)1.95%
Cap/Sales(5y)1.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-16.99%
EPS Next 2Y1.34%
EPS Next 3Y5.22%
EPS Next 5Y31.19%
Revenue 1Y (TTM)-31.25%
Revenue growth 3Y-6.45%
Revenue growth 5Y-0.74%
Sales Q2Q%25.46%
Revenue Next Year18.09%
Revenue Next 2Y18.02%
Revenue Next 3Y20.36%
Revenue Next 5Y28.25%
EBIT growth 1Y-53.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year14.41%
EBIT Next 3Y15.22%
EBIT Next 5YN/A
FCF growth 1Y68.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.75%
OCF growth 3YN/A
OCF growth 5YN/A